2010
DOI: 10.1007/s12630-009-9237-0
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of complex regional pain syndrome: a review of the evidence

Abstract: Purpose This narrative review summarizes the evidence derived from randomized controlled trials pertaining to the treatment of complex regional pain syndrome (CRPS). SourceUsing the MEDLINE

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
71
0
21

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 149 publications
(92 citation statements)
references
References 52 publications
(53 reference statements)
0
71
0
21
Order By: Relevance
“…Tran et al s' review of the evidences derived from randomized controlled trials pertaining to the treatment of complex regional pain syndrome (CRPS) showed that the use of calcitonin, vasodilators, or sympatholytic and neuromodulative intravenous regional blockade have no effects on patient pain and functional outcome (15). Ruegg S suggested that calcitonin and the biphosphonates inhibit osteoclasts and cause loss of bone mass and may reduce pain in CRPS (16).…”
Section: Discussionmentioning
confidence: 99%
“…Tran et al s' review of the evidences derived from randomized controlled trials pertaining to the treatment of complex regional pain syndrome (CRPS) showed that the use of calcitonin, vasodilators, or sympatholytic and neuromodulative intravenous regional blockade have no effects on patient pain and functional outcome (15). Ruegg S suggested that calcitonin and the biphosphonates inhibit osteoclasts and cause loss of bone mass and may reduce pain in CRPS (16).…”
Section: Discussionmentioning
confidence: 99%
“…Результаты лечения таких больных оста-ются неудовлетворительными в 30 % случаев [14][15][16][17]. Обусловлено это рядом причин.…”
Section: ââåäåíèåunclassified
“…Various different treatments, alone, or in association, including bisphosphonate, analgesic, local anethetics, physical therapy and neuromodulation have been proposed, with different, but not satisfactory, results. 3,4 Recently a double-blind placebo controlled study showed the efficacy of neridronate to reduce pain of 50% at 40 days after treatment. This study represents, so far, the best-controlled clinical evidence of therapeutic effect.…”
Section: Dicussionmentioning
confidence: 99%